TOP

Press Releases

You can read it in the journals and newspapers, or you can read it here first. Please check back frequently to see where the future is headed, compliments of Sequenom.

October 2014

Oct 6, 2014 SAN DIEGO and OXFORD, England, Oct. 6, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions and Isis Innovation Ltd., the technology transfer company of the University of Oxford, today jointly announced that Sequenom has purchased noninvasive prenatal testing intellectual property from Isis Innovation, for $14.55 million, which includes $3.2 million as the final royalty payment due to Isis under the prior... Read more

September 2014

Sep 22, 2014 SAN DIEGO, Sept. 22, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, Sequenom Laboratories, presented patient clinical data substantiating the performance of its MaterniT21® PLUS noninvasive prenatal test (NIPT) in the laboratory. An ad hoc analysis of 185,000 samples from patients at high-risk for fetal chromosome aneuploidy demonstrated stable positivity... Read more
Sep 2, 2014 SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, NY on September 8 -10, 2014. William Welch, Chief Executive Officer, and Carolyn Beaver, Chief Financial Officer, will present on Monday, September 8, beginning at 9:20 a.m. ET to provide an overview of and... Read more

August 2014

Aug 5, 2014 SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Wedbush Securities Life Sciences Management Access Conference at Le Parker Meridien in New York, NY on August 12-13, 2014. William Welch, President and Chief Operating Officer, will present on Tuesday, August 12, beginning at 4:15 p.m. ET to provide an overview of and update on the... Read more

July 2014

Jul 29, 2014 SAN DIEGO, July 29, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United States, have announced a license agreement for noninvasive prenatal testing patents and applications. "We have great appreciation for Mayo Clinic's commitment to research, innovation, and patient care, and we welcome the... Read more
62% Revenue Growth as Reimbursement and Testing Volumes Improve Jul 29, 2014 SAN DIEGO, July 29, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013. The Bioscience business segment, which was sold on May 30, 2014, has been accounted for as a discontinued... Read more

Pages